Category: Pharmaceutical

Surgical Sutures Market to See Huge Growth by 2029 | Companies Peters Surgical, Smith & Nephew, Johnson and Johnson and Boston Scientfic

Post author By administrator
Post date August 26, 2021

Surgical sutures have become a preferred choice for surgeons, and have gained significant popularity over the years. Consistent improvement in products by incorporating advanced technologies as well as government support, and government support for awareness campaigns regarding cancer radiation therapy are among the most important factors that are estimated to fuel the demand for surgical sutures during the forecast period.

According to the latest research by Fact.MR, the global surgical sutures market accounted for ~ US$ 3.9 Bn in terms of value at the end of 2018. The surgical sutures market report also projects significant growth potential with an anticipated average Y-o-Y growth rate of ~ 4% during the forecast period.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4065

Collaborative Efforts and Initiatives to Develop Absorbable Surgical Sutures

Availability of knowledge-based resources and enhanced research collaborations will improve the product development for surgical sutures. An important factor in the competition is the timing of market introduction of new products. The speed with which companies can develop products and complete clinical testing and regulatory clearance processes will decide how much they can increase their market share. Moreover, growing focus on clinical trials to enrol new surgical sutures products will further help the market. The success rates for these clinical trials to meet the endpoints and obtain key approval are marginally higher than those of currently available products.

surgical sutures market 01

In addition, there has been increasing burden of disease and growing number of surgeries, which is a positive factor for wound closure product markets. The importance of patient outcomes with assurance of better surgical recoveries is also important to drive the growth of the surgical sutures market. It is equally important for the payers, regulators, and healthcare facilities to not only focus on patient outcomes but also on quality outcomes. A change in reimbursement policy covering more medication or treatment is also expected to drive the market of surgical sutures. Amongst surgical sutures, the usage of absorbable surgical sutures is growing rapidly, and is the main driver for the growth of the surgical sutures market in emerging markets.

According to Fact.MR, the high demand for absorbable sutures and the higher Average Selling Price (ASP) have led the segment to experience more dynamic growth than any other product in the surgical sutures market. Additionally, increase in disposable incomes leading to affordability to surgical treatment in emerging countries is also inciting patients to opt for surgical sutures. However, lower adoption of surgical sutures is observed in some of the poor or lower income nations due to their poor economy.

Therefore, rise in disposable income is expected to be an important factor that is anticipated to drive the growth of the market of surgical sutures globally. It also provides an excellent growth opportunity for the surgical suture manufacturers to get connected to potential customers. One of the primary drivers for the surgical sutures market is also the increasing number of surgical procedures, especially propelled by an aging population.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=4065

Aging populations have greater risk of developing diseases and health conditions, necessitating the need for surgical interventions. This trend will drive higher volumes of both open and minimally invasive procedures, generating greater sales of suturing devices.

FMR has segmented the surgical sutures market to offer a comprehensive taxonomy of the surgical sutures market based on product type, raw material, source, application, end user, and region. By product type, the surgical sutures market is segmented into absorbable and non-absorbable. By source, the surgical sutures market is segmented into natural, synthetic, coated, and uncoated.

Get More Insights- https://www.prnewswire.com/news-releases/consumables-spearhead-gains-in-histopathology-testing-equipment-market-as-sales-likely-to-reach-us-5-5-billion-in-2018-says-fact-mr-888579674.html

By application, the surgical sutures market is further segmented into cardiovascular procedures, general surgery procedures, ophthalmic procedures, orthopedic procedures, dental procedures, gastroenterology procedures, gynaecology procedures, plastic surgery procedures, and veterinary procedure. By end user, the market is segmented into hospitals, specialized clinics, ambulatory surgical centres, veterinary hospitals and veterinary clinics. Based on raw material, surgical sutures can be categorised into nylon, silk, stainless steel, catgut, polyglycolic acid, and polygalactin, polydioxanone, and various polyester-based materials. By region, the surgical sutures market is segmented into North America, Latin America, Europe, South Asia, East Asia, Oceania, and MEA.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/4065/surgical-sutures-market
Press Release: https://www.factmr.com/media-release/1061/global-surgical-sutures-market
Follow Us: LinkedIn | Twitter

Tags Surgical Sutures Market, Surgical Sutures Market forecast, Surgical Sutures Market growth, Surgical Sutures Market insights, Surgical Sutures Market report, Surgical Sutures Market shares, Surgical Sutures Market size, Surgical Sutures Market survey, Surgical Sutures Market trends

Pharmaceutical

Vestibular Testing System Market is expected to expand at a CAGR of 6.6% over the forecast period 2021-2028

Post author By administrator
Post date August 26, 2021

Fact.MR delivers key insights on the global demand for vestibular testing system market in its upcoming report titled “Vestibular Testing Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”. In terms of revenue, the global vestibular testing system market is projected to register a CAGR of 6.8% over the forecast period, owing to various factors, regarding which FMR offers detailed insights and forecasts in this report.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=1313

The vestibular testing system market is segmented based on product type, end users and regions. Based on product type, the vestibular testing system market has been segmented into videonystagmography (VNG) systems; vestibular evoked myogenic potential (VEMP) system; rotary chair; and computerized dynamic Posturography (CDP). Among these four product types, the videonystagmography systems is expected to be the leading segment in the vestibular testing system market by 2018 end.

The increasing adoption of VNG system for vestibular testing due to its low cost and ease of use, which is likely to contribute to the growth of the vestibular testing system market in the coming future. Based on end users, the vestibular testing system market is segmented into hospitals and private clinics. The hospitals segment is expected to account a relatively high revenue share in the vestibular testing system market, due to developing hospital infrastructure.

Hospitals Continue Being the Largest Revenue Source for Vestibular Testing System Market

North America is expected to gain popularity over the forecast period in overall vestibular testing system market, driven by rising prevalence of vertigo disease, and increasing patient pool suffering from balance disorder. An increase in adoption of medicinal treatment for dizziness, and or inner ear disorder, increase in healthcare spending, growing awareness, and technological advancements are also propelling the growth of the vestibular testing system market globally. Furthermore, rise in geriatric population is also one of the key factors driving the demand for vestibular testing systems in testing facilities (including hospitals and private clinics).

In elderly population, the prevalence of vertigo and dizziness has reached up to 30%, which reflects the rapid increase in number of patients over the past few years. However, less geographical presence of key players operating in the global vestibular testing system market has led to low penetration of product in most of the countries, which is expected to hamper the growth of the vestibular testing market in various potential geographies.

Besides, unawareness among patients regarding the vestibular testing systems in under developed countries are some of other the factors expected to hamper the growth of the global vestibular testing system market over the forecast period.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=1313

A key trend witnessed in the vestibular testing system market is the promising result of videonystagmography systems and computerized dynamic posturography. Furthermore, the growing awareness about vestibular testing system, and present results by the major players to enhance product portfolio are the other key trends of global vestibular testing system market.

North America is expected to be the dominant regional market for vestibular testing system, which accounted maximum revenue share of the market in 2017. The North America, Western Europe, and Asia Pacific markets collectively accounted more than 70% share of the global vestibular testing system market in 2017. In terms of revenue, APECJ is expected to expand at the CAGR of 8.0% over the forecast period, excluding China and Japan in vestibular testing system market.

Some of the key players operating in the global vestibular testing system market are Natus Medical Incorporated, balanceback (Vestibular Research & Development, LLC), BioMed Jena GmbH, Interacoustics A/S, Neuro Kinetics, Inc (NKI), Micromedical Technologies, Difra s.a., Synapsys, TECHNO CONCEPT, Framiral, etc. In this report, we have discussed the individual strategies followed by these companies regarding bringing improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives.

Explore Fact.MR’s Coverage on the Healthcare Domain

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/1313/vestibular-testing-market
Press Release: https://www.factmr.com/media-release/545/vestibular-testing-market
Follow Us: LinkedIn | Twitter

Tags demand for the vestibular testing system, global vestibular testing system market, Vestibular testing system, Vestibular Testing System Demands, Vestibular Testing System Market, Vestibular Testing System Market analysis, Vestibular Testing System Market intelligence, Vestibular Testing System Market report, Vestibular Testing System Market research report, Vestibular Testing System Market share, Vestibular Testing System Market size, Vestibular Testing System Market strategy, Vestibular Testing System Market survey, Vestibular Testing System Market trends

Pharmaceutical

Dual Chamber Prefilled Syringes Market- North America to Remain Most Remunerative Region in terms of Revenue, Finds Fact.MR

Post author By administrator
Post date August 26, 2021

According to Fact.MR’s recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period (2021-2026). Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026-end.

Dual Chamber Prefilled Syringes – Efficient Solution for Reconstituting Lyophilized Drugs during Administration

There has been an incessant requirement for reconstituting the lyophilized drugs during their administration, along with growing necessity of tackling potential compliance and safety issues associated with the reconstitution. This has further led to the development of syringes that are capable of curtailing number of steps required for the reconstitution of drugs and making them available for injection. Dual chamber prefilled syringes are the most efficient solution to cater this requirement, as they enable immediate reconstitution within the syringe just prior to injection.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=486

Dual chamber prefilled syringes seek widespread utilization in storing biological substances and active pharmaceutical components, which cannot retain their stability for extended duration. These devices enable elimination of drug loss through maintenance of the drugs’ sterility prior to injection. Advancements in technology have resulted into improvements in the arrangement of liquid components in the syringes and injectors, while attracting more patients in opting for these efficient & safe syringes.

Lyophilized drugs have represented a robust penetration worldwide in the recent past. Lyophilized drugs account for largest share of all reconstitution-requiring injectable/infusible drugs. As a large number of injectable/infusible drugs have been developed for self-administration, special challenges are incurred for the drug developers.

However, dual chamber prefilled syringes, which are particularly designed for simplifying reconstitution devoid of patient handling of diluent or drug, have become the mainstay option for delivering these drugs, meanwhile curtailing challenges faced by developers. With lyophilized drugs witnessing proliferated penetration, demand for dual chamber prefilled syringes will gain a significant upsurge in the foreseeable future.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=486

5 Key Takeaways from Fact.MR’s Report on Dual Chamber Prefilled Syringes Market for Forecast Period 2017-2026

Sales of dual chamber prefilled syringes are expected to record the fastest expansion in online pharmacies through 2026, trailed by retail pharmacies that will account for a relatively larger market revenue share than online pharmacies by 2026-end.
In terms of revenues, hospital pharmacies will continue to be the leading contributor to the global dual chamber prefilled syringes market.
Based on product material, glass prefilled syringes are anticipated to remain sought-after in the market, with sales projected to exceed US$ 2,000 Mn in revenues by 2026-end. Plastic prefilled syringes will exhibit a relatively higher CAGR in the market through 2026.
On the basis of product type, conventional prefilled syringes are expected to account for the lion’s share of the market during 2017 to 2026. Safety prefilled syringes will account for nearly 30% revenue share of the market through the forecast period.
North America is likely to prevail as the fast-expanding as well as the most lucrative market for dual chamber prefilled syringes, followed by Europe. Asia-Pacific excluding Japan (APEJ) will also account for a major chunk of the market’s revenue share during the forecast period.

With trends of surging demand for self-injection syringes, and the development of advanced dual chamber prefilled syringes, major players in the market have directed their concentration toward product portfolio expansion. In this rapidly evolving and highly competitive market, several players are emphasizing on essentiality of the up-to-date information, in a bid to monitor their performance and make critical decisions apropos to profitability & growth. Few market players are also focusing on improvements in design of the dual chamber prefilled syringes in order to enhance the stability as well as safety of various sensitive drugs.

Key players actively underpinning the market growth, as profiled by Fact.MR’s report, include Pfizer Inc., Amgen Inc., Boehringer Ingelheim GmbH, Nipro Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, Gerresheimer AG, Ypsomed Holding AG, West Pharmaceutical Services, Inc., Schott AG, Otsuka America Pharmaceutical, Inc., Credence MedSystems, Inc., Catalent, Inc., and Bespak Europe Ltd.

Explore Fact.MR’s Coverage on the Healthcare Domain

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/486/dual-chamber-prefilled-syringes-market
Press Release: https://www.factmr.com/media-release/425/dual-chamber-prefilled-syringes-market
Follow Us: LinkedIn | Twitter

Tags Dual Chamber Prefilled Syringes Market analysis, Dual Chamber Prefilled Syringes Market Insight, Dual Chamber Prefilled Syringes Market intelligence, Dual Chamber Prefilled Syringes Market report, Dual Chamber Prefilled Syringes Market research report, Dual Chamber Prefilled Syringes Market research surveys, Dual Chamber Prefilled Syringes Market share, Dual Chamber Prefilled Syringes Market size, Dual Chamber Prefilled Syringes Market strategy, Dual Chamber Prefilled Syringes Market survey, Dual Chamber Prefilled Syringes Market trends

Pharmaceutical

Genealogy Products and Services Market is projected to grow at 11.4% CAGR through 2024

Post author By administrator
Post date August 26, 2021

According to a recent Fact.MR study, the genealogy products and services market is likely to be valued at over US$ 3 billion in 2019. The market is likely to continue its bullish run with a myriad of factors influencing the strategy of key players. Surging demand for genetic and DNA testing in an assortment of industries, coupled with the growing awareness about genealogy are some of the vital factors bolstering market growth. Technological advancement also remains a key influencer, as efficient data storage and retrieval become key priorities for market players.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=3083

Demand for genealogy in tracing lineage and creating family trees is on the rise with service providers using aggressive marketing techniques to draw in new consumers. Commercials promoting self-discovery through lineage tracing are increasingly finding greater appeal as they resonate with the human psychology of tracing their heritage in order to gain a sense of wider connection. Additionally, the concept is being popularized by an array of television programs such as “Who Do You Think You Are?” and features providing information about the ancestry of famous personalities and linking it to their career and life.

According to the study, in addition to curiosity about culture and heritage, lack of formal records is also promoting the growth of the market. For instance, demand for tracing lineages in China is on the rise with a significant percentage of population eager to trace their genealogy owing to the lack of records that were destroyed during wars in China and the Cultural Revolution. The Fact.MR study finds that the family records segment is one of the largest in the genealogy products and services market, accounting for nearly 45% of total share.

The substantial reduction in the costs of DNA sequencing technology is also aiding genealogy products & services companies to find an extensive consumer base. Reduction in the size of DNA testing kits and the convenience it offers to consumers is another key cause behind the surge in demand for genealogy products & services.

DNA Testing Finding Greater Penetration in Forensics

DNA and genetic testing is gradually gaining traction in the field of forensics with sophisticated technology and sequencing techniques enabling efficient investigation. Advancement in genetic testing is allowing forensics departments to identify suspects using smaller and mixed DNA samples which, in turn, can aid in solving complex crimes. These factors are boosting the adoption of genealogy products and services in the forensics domain.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=3083

According to the Fact.MR study, concerns surrounding the misuse of genealogy products and services are creating clamor for imposing strict regulations on market functioning. Use of genealogy products and services has been linked to the creation of predictive criminal profiles which can potentially influence policing decisions. Additionally, increasing instances of police departments basing their decision on the analysis of the DNA databases created using direct-to-consumer genetic testing data is raising concerns about the system in place. These factors could potentially restrain market growth with consumers becoming increasingly aware of the drawbacks of participating in genetic testing.

The Fact.MR report tracks the genealogy products and services market for the period 2018-2024. According to the report, the genealogy products and services market is projected to grow at 11.4% CAGR through 2024.

Explore Fact.MR’s Coverage on the Healthcare Domain

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/3083/genealogy-products-services-market
Press Release: https://www.factmr.com/media-release/926/genealogy-products-services-market
Follow Us: LinkedIn | Twitter

Tags Genealogy Products and Services Demand, Genealogy Products and Services Market, Genealogy Products and Services Market Forecast, Genealogy Products and Services Market Growth, Genealogy Products and Services Market insight, Genealogy Products and Services Market Insights, Genealogy Products and Services Market Report, Genealogy Products and Services Market share, Genealogy Products and Services Market size, Genealogy Products and Services Market Trends, Genealogy Products and Services Sales

Pharmaceutical

Intravascular Warming Patient Temperature Management Systems Market will Remain Consolidated Among Top Tiered Companies : Fact.MR

Post author By administrator
Post date August 26, 2021

Patient temperature management systems have become a necessary part of several types of medical treatments. For example, patient temperature management systems are used in surgeries to prevent excessive blood loss and for a rapid recovery post-surgery. In some cases such as heart surgeries, the body heat of a patient is reduced, which is done through the process of blood cooling and this done for reducing surgical complications. Even for patients undergoing treatment for cancer, patient temperature management systems are used to raise the body temperature for effective and efficient chemotherapy or radiation therapy procedures.

The global sales of patient temperature management systems are slated to touch a value of nearly US$ 2,860 Mn in the year 2022 and grow at a steady CAGR during the assessment period.

Patient temperature management systems are also used in neonatal care, where in order to reduce body temperature fluctuations in new born babies, they are kept in incubators. With a going number of surgeries throughout the world, the market for patient temperature management systems is increasing manifold. However, the high cost associated with patient temperature management systems may hamper the market growth.

For detailed insights on enhancing your product footprint, request for a sample here-

https://www.factmr.com/connectus/sample?flag=S&rep_id=171

4 Forecast Highlights on Global Patient Temperature Management Systems Market

As per the forecast of Fact.MR, the surface warming systems segment is slated to touch a value of nearly US$ 700 Mn in the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The surface warming systems segment is estimated to account for nearly one-fourth of the revenue share of the product type segment by the year 2017 end and is expected to gain in market share by the year 2022 end.
As per the forecast of Fact.MR, the ambulatory surgical centers segment will reach a value of nearly US$ 590 Mn in the year 2017. This represents a moderate CAGR growth during the forecast period. The ambulatory surgical centers segment is estimated to account for more than one-fifth of the revenue share of the end user segment in the year 2017 end and is expected to lose market share by the end of the year 2022.
As per the forecast of Fact.MR, the perioperative care segment is slated to reach a value of nearly US$ 940 Mn in 2022. The perioperative care segment is expected to gain some market value by the end of the year 2022. The largest share is contributed by the North America region in the perioperative care segment.
Fact.MR forecasts the neonatal care segment to grow from nearly US$ 305 Mn in 2017 to more than US$ 410 Mn in 2022. This represents a compound annual growth rate (CAGR) of 6.5% from 2017 to 2022.

Speak to Research Analyst:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=171

The report has also profiled leading players in the global market for patient temperature management systems, which will remain active through 2022. These include companies such as

3M Company
Stryker Corporation
Gentherm Incorporated
Smiths Group plc
C. R. Bard, Inc.
Medtronic plc
Inspiration Healthcare Group plc
Asahi Kasei Corporation.

Full Access of this Report Is Available At

https://www.factmr.com/checkout/171

Following Questions Answers Covered in the Report are:

How will the global Patient Temperature Management Systems Market perform during the forecast period? What will be the market size in terms of value and volume?
Which segment will drive the global Patient Temperature Management Systems Market? Which regional market will show extensive growth in the future? What are the reasons?
How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
What are the key strategies adopted by players to sustain themselves in the global Patient Temperature Management Systems Market?
How will these strategies influence the market growth and competition?

Free Mindfulness Meditation Apps to Gain Trajectory Boost during 2021-2031 –

https://www.youtube.com/watch?v=MCEzxHyNzHc

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Acute Care Patient Temperature Management Systems Market, Conventional Cooling Patient Temperature Management Systems Market, Conventional Warming Patient Temperature Management Systems Market, Emergency Care Patient Temperature Management Systems Market, Global Patient Temperature Management Systems Market, Intravascular Cooling Patient Temperature Management Systems Market, Intravascular Warming Patient Temperature Management Systems Market, Neonatal Care Units Patient Temperature Management Systems Market, North America patient temperature management systems market, Patient Temperature Management Systems, Patient Temperature Management Systems Market, Perioperative Care Patient Temperature Management Systems Market, Surface Cooling Patient Temperature Management System Markets, Surface Warming Patient Temperature Management Systems Market

Pharmaceutical

Active Breathalyzers Gain More Popularity Over Passive Breathalyzers Unveils Fact.MR

Post author By administrator
Post date August 26, 2021

According to Fact.MR, the global breathalyzer market was valued at US$ 600 Mn in 2018, and it is anticipated to clock 7.5% Y-o-Y over 2018 to surpass US$ 645 Mn by 2019 end. The recently published report by Fact.MR analyses the growth prospects of the global breathalyzer market by studying several key influencing factors.

The study finds that the rising demand for breathalyzer s in the government agencies for law enforcement applications will continue to gain traction in 2019 with an estimated valuation of US$ 250 Mn by the year end. Such proliferated rate of adoption of breathalyzer s has encouraged the manufacturers to devise feature-rich and portable devices with utmost efficiency. As a result, a notable shift towards the convergence of technological innovation and breathalyzer devices is witnessed with an aim to provide utmost accuracy.

For detailed insights on enhancing your product footprint, request for a sample here-
https://www.factmr.com/connectus/sample?flag=S&rep_id=125

“breathalyzers are gaining popularity as a crucial diagnostic equipment in medical settings for the detection of multiple diseases, owing to the cost-efficiency, ease of use, and portability that these devices offer. With their extended applications in the diagnostics centers, the global breathalyzer market is poised to witness promising growth prospects,” says the Fact.MR report.

Breathalyzers Sales to Soar as Demand from Law Enforcement Bodies and Medical Settings Continue to Rise

Rising trends of alcohol consumption in parallel to the growing number of cars used as the primary mode of transportation have resulted in a large number of road accidents. As a result, surging demand for determining the blood alcohol content (BAC) from the government agencies is projected to positively impact the growth of the global breathalyzer market, especially in North America. According to the U.S. law, individuals with a BrAC level of 0.08% and over are prosecuted. In such cases, breathalyzer s are used as crucial evidence for criminal trials. In addition to alcohol, there is a notable increase in the proclivity of individuals for drugs consumption. As a result, the manufacturers of the breathalyzer market have been endeavoring towards enhancing the functionality of their products to detect the cases of drug abuse.

Speak to Research Analyst:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=125

According to the report, breathalyzer s also find their applications in the medical field. Surging demand for breathalyzer s in diagnostics centers and hospitals is attributed to the excellent ability of such devices to diagnose asthma, tuberculosis, and pylori infection, which in turn, eliminates the need for multiple blood sample tests. This paves way for the growth of the global breathalyzer market.

Concerns Over Reliability and Hygiene Continue to Impede Sales

Fact.MR predicts limited growth opportunities for the global breathalyzer market, owing to the inefficiency of the devices to detect alcohol from other chemical compounds consisting of a methyl group structure. Additionally, lip glosses, mouthwash, dentures, and asthma inhalers can modify the results of the devices. Such inaccuracies in the results could pose a challenge to the adoption rate of these devices. Another crucial restraint for the breathalyzer market is the unhygienic conditions and rising health concerns, owing to which drivers hesitate to undergo such tests.

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=125

Fuel Cell Technology Holds Over Half of the Total Revenue Acquired by the breathalyzer Market

As per the report, fuel cell technology is more favored over semiconductor sensor technology, on account of its portability, alcohol specificity, and accuracy. Fact.MR forecasts that the fuel cell segment will register a valuation of over US$ 380 Mn in the breathalyzer market by 2019. The technology holds over half of the total revenue acquired by the global breathalyzer market and it is predicted to hold the largest share in the technological segment with North America contributing massively to its growth.

The Fact.MR research report analyzes the breathalyzer market for the period 2012 – 2022. According to the study, the global breathalyzer market is expected to grow at a promising CAGR through 2022.

For More Insights
https://www.biospace.com/article/hiv-associated-nephropathy-treatment-demand-driven-by-increase-in-accessibility-of-new-drugs-with-enhanced-efficacy-says-fact-mr/

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Breathalyzer Market, Breathalyzer Market Insight, Breathalyzer Market intelligence, Breathalyzer Market report, Breathalyzer Market research report Breathalyzer Market analysis, Breathalyzer Market research surveys, Breathalyzer Market share, Breathalyzer Market size, Breathalyzer Market strategy, Breathalyzer Market survey, Breathalyzer Market trends

Pharmaceutical

Sales of Linear Accelerators Devices for Radiotherapy Is Expected to Gain Steadfast Traction, Procuring an Annual Growth of More than US$ 1.9 Bn

Post author By administrator
Post date August 26, 2021

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

With increasing risks of obtaining cancer treatment through chemotherapy, patients, as well as medical professionals, are turning towards radiotherapy as a sought-after oncological treatment for cancers. The Fact.MR report on the global revenue share of radiotherapy devices predicts that towards the end of 2022, more than US$ 7 Bn worth of devices will be sold across the globe, reflecting a stellar CAGR. Following insights from the report will offer a comprehensive outlook on the future of radiotherapy devices in the global healthcare industry during 2017-2022.

For detailed insights on enhancing your product footprint, request for a sample here-

https://www.factmr.com/connectus/sample?flag=S&rep_id=77

Market Taxonomy

By Product Type	By End User
Linear Accelerators Devices	Hospitals
Proton Therapy Devices	Ambulatory Surgical Centers
Brachytherapy Devices	Oncological Treatment Centers
Others

Speak to Research Analyst:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=77

Key Projections on the Global Radiotherapy Devices Market:

In 2017, global sales of linear accelerator devices is expected to procure nearly half of global radiotherapy devices market value. The sales of linear accelerators for radiotherapy is expected to gain steadfast traction, procuring an annual growth of more than US$ 280 Mn from 2017 to 2022.
With soaring incidence of cancers across European countries, the healthcare infrastructure in this region is expected to remain lucrative for adoption of effective cancer therapies such as radiotherapy. The demand for radiotherapy devices is expected to gain traction in Europe owing to its advantage over other cancer therapeutic devices in terms of controlling the growth of the malignant tumors. Moreover, cancer patients are likely to remain more inclined towards radiotherapy devices that limit the hospital stay duration. According to the report, Europe will remain the largest market for radiotherapy devices throughout the forecast period.
In North America, changing lifestyles of consumers and penetration of urban cultures is fuelling the incidence of pancreatic cancer. Radiotherapy devices are expected to remain of great use in treatment of pancreatic cancer and borderline resectable cancer. The radiotherapy devices market in North America is expected to witness robust gains throughout the forecast period.
Manufacturers of radiotherapy devices are expected to view the Asia-Pacific excluding Japan (APEJ) region as lucrative for setting up production units. Favorable industrial regulations, low wages and high resource availability is expected to drive the growth of radiotherapy devices market in the APEJ region. The report predicts that the APEJ radiotherapy devices market is expected to grow at the fastest pace, reflecting a stellar CAGR of 11.5% through 2022.
Towards the end of 2022, hospitals will emerge to be the largest end-users of radiotherapy devices. The demand for radiotherapy devices in oncological treatment centers is also anticipated to gain traction, procuring over one-fourth share on global market values throughout the forecast period.

For More Insights: https://www.biospace.com/article/hiv-associated-nephropathy-treatment-demand-driven-by-increase-in-accessibility-of-new-drugs-with-enhanced-efficacy-says-fact-mr/

The report has profiled leading manufacturers of radiotherapy devices which are expected to remain active in the expansion of global market, and these include Varian Medical Systems, RaySearch Laboratories AB, Theragenics Corp, Toshiba Medical Systems Corporation, Elekta AB, Accuray, Inc., IsoRay, Inc., GE Healthcare, Vision RT Ltd., C.R. Bard, Inc., Koninklijke Philips N.V., Siemens AG, IBA Ion Beam Applications SA, Eckert & Ziegler Bebig, Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, Neusoft Medical Systems Co., Ltd. and AngioDynamics, Inc.

Full Access of this Exclusive Report is Available at-

https://www.factmr.com/checkout/77

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Radiotherapy Devices Market, Radiotherapy Devices Market Forecast, Radiotherapy Devices Market Growth, Radiotherapy Devices Market insights, Radiotherapy Devices Market Report, Radiotherapy Devices Market Share, Radiotherapy Devices Market Size, Radiotherapy Devices Market Survey, Radiotherapy Devices Market trends

Pharmaceutical

OTC Herbal and Traditional Medicines Sales In Online OTC Channel Is Expected To Register the Fastest Expansion

Post author By administrator
Post date August 26, 2021

Fact.MR, in its new report, estimates the global sales of OTC herbal and traditional medicines to register a moderate 4.8% CAGR over the forecast period 2017 to 2022. The report anticipates the revenues share of OTC herbal and traditional medicines to surpass US$ 30,000 Mn by 2022-end.

A number of reputed research organisations, such as AYUSH, and the Dabur Research & Development Center, are concentrating on research & development activities associated with the herbal and traditional medicines. Although, herbal and traditional systems of medicines have valuable elements, they comprise of ingredients which may be harmful for human health, and could result into side-effects.

For detailed insights on enhancing your product footprint, request for a sample here-

https://www.factmr.com/connectus/sample?flag=S&rep_id=72

Two aspects are considered for safety evaluation, which are determining right quality of ingredients, and preventing contamination/adulteration of ingredients used for these medicines. This has further necessitated prescription from physicians prior to consumption of herbal and traditional medicines. The transforming environment of healthcare sector across the globe generates the requirement for comprehensive policy review regarding traditional and herbal systems of medicines.

Market Taxonomy

Function	Immune Health Digestive Health Heart Health Nutrition Bone & Joint Health General Well being Weight Loss Other Functions
OTC Channel	Pharmacy Drug Store Modern Trade Online Other OTC Format
Dosage	Liquid Capsule Tablet Powder

Speak to Research Analyst:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=72

10 Predictions for the Global OTC Herbal and Traditional Medicines Market

Asia-Pacific excluding Japan (APEJ) will be dominant in the global OTC herbal and traditional medicines market in 2017, and is expected to retain its dominance and exhibit a steady expansion through 2022.
By 2022-end, North America will continue to be the second most lucrative market for OTC herbal and traditional medicines.
Japan is anticipated to remain the least lucrative market for OTC herbal and traditional medicines.
Based on function, Revenues from OTC herbal and traditional medicine sales for maintenance of the people’s digestive health are estimated to account for largest revenues by 2022-end.
OTC herbal and traditional medicine sales for bone & joint health, and nutrition are estimated to register parallel expansion at a similar CAGR. However, revenues from nutrition segment is expected to remain comparatively higher than bone & joint health.
Modern trade OTC channel is expected to remain preferred among consumers for buying of OTC herbal traditional medicines.
OTC herbal and traditional medicine sales in online OTC channel is expected to register the fastest expansion over the forecast period.
Pharmacy OTC channel are expected to account for larger market revenue share, however sales are estimated to register a sluggish expansion throughout the forecast period.
Based on dosage, powdered form of OTC herbal and traditional medicines are expected to remain preferred among consumers. Revenues from this segment is estimated to exceed US$ 10,000 Mn by 2022-end.
Between liquid and tablet form of OTC herbal and traditional medicines, sales of tablet dosage are expected to account for larger revenues, while sales of liquid OTC herbal and traditional medicines are expected to exhibit a comparatively faster expansion through 2022.

Full Access of this Report Is Available at

https://www.factmr.com/checkout/72

The report has also profiled leading players in the global market for OTC herbal and traditional medicines, which include

Amway Corporation
Phytomed Herbal Solutions
Herbalife International
Biovontrade SARL
The Himalayan Drug Company
Nutra Green Biotechnology Co., Ltd.
Naturex SA
Bio-Botanica, Inc.
Nutraceutical International Corporation
The Nature’s Bounty Co.
Medico Herbs
The Bioforce Group
Jiaherb Inc.
Ricola AG

For More Insights

https://www.biospace.com/article/factor-xiii-deficiency-treatment-continues-to-be-centered-around-fresh-frozen-plasma-study/

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags OTC Herbal and Traditional Medicines Market, OTC Herbal and Traditional Medicines Market forecast, OTC Herbal and Traditional Medicines Market growth, OTC Herbal and Traditional Medicines Market insights, OTC Herbal and Traditional Medicines Market report, OTC Herbal and Traditional Medicines Market survey, OTC Herbal and Traditional Medicines Market trends

Pharmaceutical

North America’s Demand for C-kit/CD117 Tests Is Anticipated to Account for Nearly US$ 800 Mn In Revenues by 2022-end

Post author By administrator
Post date August 26, 2021

The global demand for colorectal cancer diagnostics is anticipated to exhibit an impressive expansion at a CAGR of 8.5% during the forecast period 2017 to 2022, according to a report by Fact.MR. Global revenues from the market are projected to surpass US$ 2,000 Mn by 2022-end.

For detailed insights on enhancing your product footprint, request for a sample here-
https://www.factmr.com/connectus/sample?flag=S&rep_id=70

Market Taxonomy

Test Type	End User
FOB	Hospital Associated Labs
CTC Tests	Independent Diagnostic Laboratories
BRAF V600 Mutations	Cancer Research Institutes
CEA Tests	Others
C-kit/CD117
KRAS Mutation Tests
Immunohistochemistry
Others

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Speak to Research Analyst:
https://www.factmr.com/checkout/70

According to the World Cancer Research Fund, colorectal cancer forms the third-most occurring type of cancer across the globe. In 2012, over 1 Mn cases of colorectal cancer were diagnosed. Majority of these cases were reported across developed economies, and this is further estimated to exceed in the near future. This rise in incidences of colorectal cancer has boosted demand for its diagnostics, treatment, and therapeutics worldwide. However, the number of deaths owing to colorectal cancer has been witnessing a decline since recent past, owing to the awareness spread by the American Cancer Society. The introduction of more effective diagnostics, and development of screening methods are further expected to drive growth of the global colorectal cancer diagnostics market.

The advent of new diagnostic tests, increasing uptakes of diagnosis-associated therapies, and initiatives taken by private as well as government organisations are some factors expected to propel growth of the global market for colorectal cancer diagnostics. Increasing unmet requirements across several emerging economies, coupled with the absence of neoadjuvant and adjuvant pipeline agents for diagnosing high-risk patients affected with resectable colorectal cancer is expected to create huge growth opportunities for leading players in the market. However, factors such as growing reluctance towards medications of colorectal cancer by patients, and unawareness across several remote regions of the globe is expected to inhibit the market growth.

For More Insights:
https://www.biospace.com/article/increasing-demand-from-cosmetic-and-semiconductor-industries-is-shaping-growth-of-in-situ-particle-measurement-market-fact-mr/

6 Key Projections for the Global Colorectal Cancer Diagnostics Market

North America will continue to be the most lucrative region for the colorectal cancer diagnostics market. Revenue from market in North America is expected to surpass US$ 800 Mn by 2022-end.
The colorectal cancer diagnostics market in Asia Pacific excluding Japan (APEJ) is expected to register the fastest expansion during the forecast period. However, revenue from the market in Middle East & Africa (MEA) will continue to be sluggish during the forecast period.
By test type, FOB will continue to be the largest adopted test for diagnosis of colorectal cancer across the globe. Revenue from FOB tests for colorectal cancer diagnostics will remain largest, followed by CTC tests.
Immunochemistry tests for colorectal cancer diagnostics will exhibit the highest CAGR through 2022. However, revenue from BRAF tests will remain the lowest in the global colorectal cancer diagnostics market during the forecast period.
On the basis of end-users, although hospital-associated labs will remain sought-after in the market, cancer research institutes will continue to register the fastest expansion during the forecast period.
Revenues from hospital-associated labs for colorectal cancer diagnostics are expected to reach nearly US$ 1,000 Mn by 2022-end. Independent diagnostic laboratories will continue to be the second most lucrative end-users in the global colorectal cancer diagnostics market.

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=70

The report also includes a comprehensive landscape of global market for colorectal cancer diagnostics, where companies namely

Illumina, Inc.
Foundation Medicine, Inc.
Sysmex Corporation
Cancer Genetics, Inc.
Danaher Corporation
Biocept, Inc
Pathway Genomics Corporation
Rosetta Genomics
Epigenomics AG
Exact Science Corporation

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Colorectal Cancer Diagnostics Market, Colorectal Cancer Diagnostics Market Forecast, Colorectal Cancer Diagnostics Market Growth, Colorectal Cancer Diagnostics Market Insights, Colorectal Cancer Diagnostics Market Report, Colorectal Cancer Diagnostics Market Size, Colorectal Cancer Diagnostics Market Survey, Colorectal Cancer Diagnostics Market Trend

Pharmaceutical

Respiratory Syncytial Virus (RSV) Diagnostics Market Globally Expected to Drive Growth through 2031

Post author By administrator
Post date August 25, 2021

Respiratory Syncytial Virus (RSV) Diagnostics Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Respiratory Syncytial Virus (RSV) Diagnostics insightful data for the specific country/regions. The study analyses crucial trends that are currently determining the growth of the Respiratory Syncytial Virus (RSV) Diagnostics market

The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Respiratory Syncytial Virus (RSV) Diagnostics market and quantified with insightful rationale.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=6736

Key Parameters analyzed while estimating the Respiratory Syncytial Virus (RSV) Diagnostics market include:

To analyze Drugs/ Therapeutic Area in Respiratory Syncytial Virus (RSV) Diagnostics :

Overall Population by age group/Prevalence or Incidence of any disease/Treatment Seeking Rate/Dosage pattern/Average duration of treatment/Overall treatment cost and Reimbursement are considered.

To analyze Consumables of Respiratory Syncytial Virus (RSV) Diagnostics:

Overall Population/Prevalence or Incidence of disease/treatment seeking rate/ average duration of the treatment/average number of devices used per patient / average number of procedure per device/ average selling price per device/reimbursement are considered.

To analyze Respiratory Syncytial Virus (RSV) Diagnostics Equipment:

Number of Healthcare facilities (Hospitals/Ambulatory Surgical Centers/Clinics etc.)

Average number of devices installed per facilities/ lifespan of the devices/replacement rate of the equipment/new sales of the equipment per year/average selling price per equipment are considered.

Some of the Respiratory Syncytial Virus (RSV) Diagnostics Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides:

Details regarding latest innovations and development in Respiratory Syncytial Virus (RSV) Diagnostics and how it is gaining customer traction during the forecast period.
Analysis about the customer demand of the products and how it is likely to evolve in coming years.
Latest regulations enforced by government bodies and local agencies and their impact on Demand of Respiratory Syncytial Virus (RSV) Diagnostics Market .
Insights about adoption of new technologies and its influence on the Respiratory Syncytial Virus (RSV) Diagnostics market Size.
Overview of the impact of COVID-19 on Respiratory Syncytial Virus (RSV) Diagnostics Market and economic disruptions caused by the pandemic.
Evaluates post-pandemic impact on the Sales of Respiratory Syncytial Virus (RSV) Diagnostics Market during the forecast period.

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=6736

Key Market Segments Covered in Respiratory Syncytial Virus Diagnostics Industry Research

By Technology
- RSV Molecular Diagnostics
- RSV Monoclonal Antibodies
- Immunoassays
- Differential Light Scattering
- Artificial Intelligence
- Liposomes
- Flow Cytometry
- Chromatography
- Diagnostic Imaging
- Gel Microdroplets
By End Users
- Respiratory Syncytial Virus Diagnostics at Hospitals
- Respiratory Syncytial Virus Diagnostics at Nursing Homes
- Respiratory Syncytial Virus Diagnostics at Commercial Laboratories
- Respiratory Syncytial Virus Diagnostics at Public Health Laboratories

Some Notable Offerings by Fact.MR Report on Respiratory Syncytial Virus (RSV) Diagnostics market:

We will provide you an analysis of the extent to which this Respiratory Syncytial Virus (RSV) Diagnostics market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
Also, this report will help you to identify any trends to forecast growth rates.
The analyzed report will forecast the general tendency for supply and demand.

Key Highlights from the Respiratory Syncytial Virus (RSV) Diagnostics Report :

Elaborated scenario of the parent market
Transformations in the Respiratory Syncytial Virus (RSV) Diagnostics market dynamics
Detailed segmentation of the target market
Historical, current and forecast of Respiratory Syncytial Virus (RSV) Diagnostics market size based on value and volume
Latest industry developments and Market trends of Respiratory Syncytial Virus (RSV) Diagnostics
competitive analysis of Respiratory Syncytial Virus (RSV) Diagnostics Market
Strategies adopted by the Respiratory Syncytial Virus (RSV) Diagnostics market players and product developments made
Potential and niche segments, along with their regional analysis
Unbiased analysis on market size of Respiratory Syncytial Virus (RSV) Diagnostics
Up-to-date and must-have intelligence for the market players to enhance and sustain their competitiveness

To Get All-in Insights on The Regional Landscape of The Respiratory Syncytial Virus (RSV) Diagnostics Market, Buy Now:-https://www.factmr.com/checkout/6736

After reading the Market insights of Respiratory Syncytial Virus (RSV) Diagnostics Report, readers can:

Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
Analyze key regions holding significant share of total Respiratory Syncytial Virus (RSV) Diagnostics market revenue.
Study the growth outlook of Respiratory Syncytial Virus (RSV) Diagnostics market scenario, including production, consumption, history and forecast.
Learn consumption pattern and impact of each end use & supply side analysis of Respiratory Syncytial Virus (RSV) Diagnostics market.
Investigate the recent R&D projects performed by each market player & competitive analysis of Respiratory Syncytial Virus (RSV) Diagnostics Market Players.

How Fact.MR Assists in Making Strategic Moves For Respiratory Syncytial Virus (RSV) Diagnostics Market Manufacturer?

The data provided in the Respiratory Syncytial Virus (RSV) Diagnostics market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

Watch Trending Video on Hair Dye Market Survey Report by Fact.MR – https://www.youtube.com/watch?v=Ym42mK7wZWg

About Fact.MR:

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Tags Respiratory Syncytial Virus (RSV) Diagnostics Market, Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis, Respiratory Syncytial Virus (RSV) Diagnostics Market Forecast, Respiratory Syncytial Virus (RSV) Diagnostics Market Key players, Respiratory Syncytial Virus (RSV) Diagnostics Market Price, Respiratory Syncytial Virus (RSV) Diagnostics Market Share, Respiratory Syncytial Virus (RSV) Diagnostics Market Size, Respiratory Syncytial Virus (RSV) Diagnostics Market Trend

Collaborative Efforts and Initiatives to Develop Absorbable Surgical Sutures

Hospitals Continue Being the Largest Revenue Source for Vestibular Testing System Market

Dual Chamber Prefilled Syringes – Efficient Solution for Reconstituting Lyophilized Drugs during Administration

5 Key Takeaways from Fact.MR’s Report on Dual Chamber Prefilled Syringes Market for Forecast Period 2017-2026

DNA Testing Finding Greater Penetration in Forensics

Key Market Segments Covered in Respiratory Syncytial Virus Diagnostics Industry Research

By Technology

By End Users